Get the Stockscreener App
0.628
7.17%
0.042
After Hours:
.63
0.002
+0.32%
Rein Therapeutics Inc Stock (RNTX) Forecast
The Rein Therapeutics Inc (RNTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.3408, representing a +113.51% increase from the current price of $0.628. The highest analyst price target is $2.1463, and the lowest is $0.5354.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RNTX Price Target
Average 1.0738
(+70.99% Upside)
Is Rein Therapeutics Inc (RNTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.81 | Neutral |
| STOCH(9,6) | 23.45 | Neutral |
| STOCHRSI(14) | 19.97 | Buy |
| MACD(12,26) | -0.0273 | Sell |
| ADX(14) | 21.61 | Neutral |
| William %R | -75.51 | Neutral |
| CCI(14) | -231.59 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7556
Sell
|
0.7271
Sell
|
| MA20 |
0.7688
Sell
|
0.7548
Sell
|
| MA50 |
0.7841
Sell
|
0.794
Sell
|
| MA100 |
0.8552
Sell
|
0.878
Sell
|
| MA200 |
1.0689
Sell
|
1.0174
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RNTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on RNTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.81 indicates that RNTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.45 indicates that RNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.97 indicates that RNTX is oversold. This suggests that RNTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.61 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -231.59 indicates that RNTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RNTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rein Therapeutics Inc financial reports and earnings history, Rein Therapeutics Inc (RNTX) stock could reach $0.2861 by 2030, $3.7067 by 2040 and $6.771 by 2050. See the projected annual prices until 2050 of the Rein Therapeutics Inc stock below:
- Rein Therapeutics Inc (RNTX) is expected to reach an average price of $3.8962 in 2035, with a high prediction of $4.2633 and a low estimate of $4.0762. This indicates an $520.42% rise from the last recorded price of $0.628.
- Rein Therapeutics Inc (RNTX) stock is projected to chart a bullish course in 2040, with an average price target of $3.7767, representing an $501.38% surge from its current level. The forecast ranges from a conservative $3.3046 to a sky-high $3.7067.
- Our analysts predict Rein Therapeutics Inc (RNTX) to jump 1,451% by 2045, soaring from $9.9228 to an average price of $9.7428, potentially reaching $9.8492. While $9.9228 is the low estimate, the potential upside is significant.
- Rein Therapeutics Inc (RNTX) stock is expected to climb by 2050, reaching an average of $6.5567, a $944.06% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.771 and $6.6083, respectively, highlighting the market's uncertainty.
Rein Therapeutics Inc Stock (RNTX) Year by Year Forecast
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2026
The predicted value for Rein Therapeutics Inc (RNTX) in 2026 is set at an average of $1.2478. Estimates vary from a peak of $2.1463 to a trough of $0.3494, indicating an +98.70% surge from the present price of $0.628.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.7728 | $0.5354 | $2.1463 | +23.06% |
| December, 2026 | $0.4194 | $0.3494 | $0.9646 | -33.22% |
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rein Therapeutics Inc (RNTX) is $0.6194, with a high forecast of $1.2375 and a low forecast of $0.00132. This indicates an -1.37% decrease from the last price of $0.628.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4559 | $0.0968 | $0.7085 | -27.40% |
| February, 2027 | $0.5525 | $0.2842 | $0.6851 | -12.03% |
| March, 2027 | $0.7182 | $0.4971 | $1.2016 | +14.36% |
| April, 2027 | $0.3847 | $0.2047 | $0.7873 | -38.74% |
| May, 2027 | $0.0304 | $0.0304 | $0.4839 | -95.16% |
| June, 2027 | $0.347 | $0.00132 | $0.357 | -44.75% |
| July, 2027 | $0.1735 | $0.0402 | $0.448 | -72.37% |
| August, 2027 | $0.4792 | $0.1326 | $0.5909 | -23.69% |
| September, 2027 | $0.5558 | $0.2166 | $1.2375 | -11.50% |
| October, 2027 | $0.5323 | $0.3923 | $0.6649 | -15.24% |
| November, 2027 | $0.368 | $0.1506 | $0.5914 | -41.40% |
| December, 2027 | $0.3145 | $0.2845 | $0.8063 | -49.91% |
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2028
In 2028, Rein Therapeutics Inc (RNTX) is projected to reach an average price of $0.7476, with a high projection of $1.3951 and a low estimate of $0.1002. This indicates an +19.05% rise from the last price of $0.628.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4802 | $0.2837 | $0.7102 | -23.53% |
| February, 2028 | $0.7668 | $0.3694 | $0.9768 | +22.10% |
| March, 2028 | $0.3433 | $0.3133 | $1.3951 | -45.33% |
| April, 2028 | $0.4599 | $0.2909 | $0.5625 | -26.77% |
| May, 2028 | $0.4356 | $0.2414 | $0.479 | -30.64% |
| June, 2028 | $0.2234 | $0.1898 | $0.4637 | -64.42% |
| July, 2028 | $0.2399 | $0.1444 | $0.3461 | -61.80% |
| August, 2028 | $0.3144 | $0.2144 | $0.465 | -49.94% |
| September, 2028 | $0.3449 | $0.238 | $0.4408 | -45.08% |
| October, 2028 | $0.6392 | $0.1002 | $0.7926 | +1.78% |
| November, 2028 | $0.6261 | $0.3726 | $0.3435 | -0.31% |
| December, 2028 | $0.773 | $0.7095 | $0.5912 | +23.08% |
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2029
The 2029 price forecast for Rein Therapeutics Inc Stock (RNTX) is $0.6833 on average, with a high prediction of $0.9792 and a low estimate of $0.3875. This represents an +8.81% increase from the previous price of $0.628.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7416 | $0.9099 | $0.7381 | +18.09% |
| February, 2029 | $0.3285 | $0.5085 | $0.6133 | -47.69% |
| March, 2029 | $0.7654 | $0.4919 | $0.3654 | +21.88% |
| April, 2029 | $0.794 | $0.8123 | $0.7738 | +26.43% |
| May, 2029 | $1.0309 | $0.8557 | $0.9792 | +64.16% |
| June, 2029 | $0.7378 | $0.8378 | $0.897 | +17.48% |
| July, 2029 | $0.7864 | $0.8264 | $0.8099 | +25.23% |
| August, 2029 | $0.3383 | $0.6033 | $0.5799 | -46.13% |
| September, 2029 | $0.2602 | $0.4202 | $0.3285 | -58.56% |
| October, 2029 | $0.5788 | $0.4437 | $0.4938 | -7.83% |
| November, 2029 | $0.2957 | $0.5457 | $0.4606 | -52.91% |
| December, 2029 | $0.4344 | $0.3875 | $0.3929 | -30.83% |
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2030
Rein Therapeutics Inc Stock (RNTX) is expected to reach an average price of $1.0371 in 2030, with a high forecast of $2.066 and a low forecast of $0.00816. This signifies an +65.14% surge from the last price of $0.628.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.2513 | $0.3587 | $0.2861 | -59.99% |
| February, 2030 | $0.3318 | $0.00816 | $0.4218 | -47.16% |
| March, 2030 | $0.1351 | $0.2201 | $0.6901 | -78.49% |
| April, 2030 | $0.3058 | $0.2901 | $0.2237 | -51.31% |
| May, 2030 | $0.1991 | $0.242 | $0.2355 | -68.30% |
| June, 2030 | $0.3801 | $0.2313 | $0.2875 | -39.48% |
| July, 2030 | $0.2762 | $0.2823 | $0.2767 | -56.02% |
| August, 2030 | $0.2046 | $0.2194 | $0.1317 | -67.42% |
| September, 2030 | $2.116 | $0.1521 | $2.066 | +236.94% |
| October, 2030 | $1.5663 | $1.9288 | $1.6238 | +149.42% |
| November, 2030 | $1.8967 | $1.6989 | $1.7967 | +202.02% |
| December, 2030 | $2.0496 | $1.9993 | $1.9496 | +226.37% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):